Elesclomol (STA-4783) With Paclitaxel Versus Paclitaxel Alone in Melanoma
Clinical trial NCT00522834 · TERMINATED
Trial details
- NCT number
- NCT00522834
- Sponsor
- Synta Pharmaceuticals Corp.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2009-06-01
- Enrollment
- 630
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.